ABSTRACT Patients who suffer from motion sickness despite avoiding triggers and using behavioral modifications may benefit from individualized recommendations for pharmacologic therapy. Patients with refractory motion sickness can benefit from prophylactic drug therapy using first-generation antihistamines or scopolamine.